Reviews

 2012 
 2011 
 2010 
 2009 
 2008 
 2007 
 2006 
 2005 
 2004 
 2003 
 2002 
 2001 
 2000 
 1999 


2012

  • Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals
    February 2012 (Vol. 56 | No. 2 | Pages 455-463)

    Patrice Cacoub, Marc Bourlière, Jann Lübbe, Nicolas Dupin, Peter Buggisch, Geoffrey Dusheiko, Christophe Hézode, Odile Picard, Ramon Pujol, Siegfried Segaert, Bing Thio, Jean-Claude Roujeau

  • Radioembolization for hepatocellular carcinoma
    February 2012 (Vol. 56 | No. 2 | Pages 464-473)

    Bruno Sangro, Mercedes Iñarrairaegui, Jose I. Bilbao

  • Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
    January 2012 (Vol. 56 | No. 1 | Pages 255-266)

    Christian Thoma, Christopher P. Day, Michael I. Trenell

  • Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies
    January 2012 (Vol. 56 | No. 1 | Pages 267-275)

    Jens U. Marquardt, Peter R. Galle, Andreas Teufel

2011

  • Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
    December 2011 (Vol. 55 | No. 6 | Pages 1415-1427)

    F. Violi, S. Basili, V. Raparelli, P. Chowdary, A. Gatt, A.K. Burroughs

  • HCV and the hepatic lipid pathway as a potential treatment target
    December 2011 (Vol. 55 | No. 6 | Pages 1428-1440)

    Margaret F. Bassendine, David A. Sheridan, Daniel J. Felmlee, Simon H. Bridge, Geoffrey L Toms, R. Dermot G. Neely

  • Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
    November 2011 (Vol. 55 | No. 5 | Pages 1121-1131)

    Henry Lik-Yuen Chan, Alex Thompson, Michelle Martinot-Peignoux, Teerha Piratvisuth, Markus Cornberg, Maurizia Rossana Brunetto, Hans L. Tillmann, Jia-Horng Kao, Ji-Dong Jia, Heiner Wedemeyer, Stephen Locarnini, Harry L.A. Janssen, Patrick Marcellin

  • “The city of Hepar”: Rituals, gastronomy, and politics at the origins of the modern names for the liver
    November 2011 (Vol. 55 | No. 5 | Pages 1132-1136)

    Michele Augusto Riva, Enrica Riva, Mauro Spicci, Mario Strazzabosco, Marcello Giovannini, Giancarlo Cesana

  • Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
    October 2011 (Vol. 55 | No. 4 | Pages 920-932)

    Paola Dongiovanni, Anna Ludovica Fracanzani, Silvia Fargion, Luca Valenti

  • Causality assessment methods in drug induced liver injury: Strengths and weaknesses
    September 2011 (Vol. 55 | No. 3 | Pages 683-691)

    Miren García-Cortés, Camilla Stephens, M. Isabel Lucena, Alejandra Fernández-Castañer, Raúl J. Andrade

  • IL28B single nucleotide polymorphisms in the treatment of hepatitis C
    September 2011 (Vol. 55 | No. 3 | Pages 692-701)

    Christian M. Lange, Stefan Zeuzem

  • A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation
    August 2011 (Vol. 55 | No. 2 | Pages 453-458)

    Paul C. Adams, James C. Barton

  • Epithelial–mesenchymal transition in chronic liver disease: Fibrogenesis or escape from death?
    August 2011 (Vol. 55 | No. 2 | Pages 459-465)

    Massimo Pinzani

  • ‘Easy to treat’ genotypes were not created equal: Can rapid virological response (RVR) level the playing field?
    August 2011 (Vol. 55 | No. 2 | Pages 466-473)

    Andres Duarte-Rojo, Elizabeth Jenny Heathcote, Jordan Jay Feld

  • Autoimmune hepatitis
    July 2011 (Vol. 55 | No. 1 | Pages 171-182)

    Ansgar W. Lohse, Giorgina Mieli-Vergani

  • Natural history of chronic hepatitis B in Euro-Mediterranean and African Countries
    July 2011 (Vol. 55 | No. 1 | Pages 183-191)

    Stephanos J. Hadziyannis

  • Natural history of chronic hepatitis B in Euro-Mediterranean and African Countries
    July 2011 (Vol. 55 | No. 1 | Pages 183-191)

    Stephanos J. Hadziyannis

  • Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel
    June 2011 (Vol. 54 | No. 6 | Pages 1250-1262)

    Mahmoud A. Khattab, Peter Ferenci, Stephanos J. Hadziyannis, Massimo Colombo, Michael P. Manns, Piero L. Almasio, Rafael Esteban, Ayman A. Abdo, Stephen A. Harrison, Nazir Ibrahim, Patrice Cacoub, Mohammed Eslam, Samuel S. Lee

  • The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
    June 2011 (Vol. 54 | No. 6 | Pages 1263-1272)

    Thijs W.H. Pols, Lilia G. Noriega, Mitsunori Nomura, Johan Auwerx, Kristina Schoonjans

  • Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
    June 2011 (Vol. 54 | No. 6 | Pages 1273-1285)

    Joseph Torresi, Doug Johnson, Heiner Wedemeyer

  • Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges
    June 2011 (Vol. 54 | No. 6 | Pages 1286-1296)

    Marie-Louise Michel, Qiang Deng, Maryline Mancini-Bourgine

  • Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
    May 2011 (Vol. 54 | No. 5 | Pages 1020-1029)

    Giovanni Targher, Michel Chonchol, Giacomo Zoppini, Cataldo Abaterusso, Enzo Bonora

  • New assessment of hepatic encephalopathy
    May 2011 (Vol. 54 | No. 5 | Pages 1030-1040)

    Juan Córdoba

  • Immunosuppression in liver transplant recipients with renal impairment
    May 2011 (Vol. 54 | No. 5 | Pages 1041-1054)

    C. Duvoux, G.P. Pageaux

  • Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver
    April 2011 (Vol. 54 | No. 4 | Pages 773-794)

    Karima Begriche, Julie Massart, Marie-Anne Robin, Annie Borgne-Sanchez, Bernard Fromenty

  • Endoplasmic reticulum stress in liver disease
    April 2011 (Vol. 54 | No. 4 | Pages 795-809)

    Harmeet Malhi, Randal J. Kaufman

  • Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
    March 2011 (Vol. 54 | No. 3 | Pages 566-576)

    Mirjam B. Zeisel, Isabel Fofana, Samira Fafi-Kremer, Thomas F. Baumert

  • Liver antigen-presenting cells
    February 2011 (Vol. 54 | No. 2 | Pages 357-365)

    Ian Nicholas Crispe

  • Hedgehog signaling in the liver
    February 2011 (Vol. 54 | No. 2 | Pages 366-373)

    Alessia Omenetti, Steve Choi, Gregory Michelotti, Anna Mae Diehl

  • Hepcidin in human iron disorders: Therapeutic implications
    January 2011 (Vol. 54 | No. 1 | Pages 173-181)

    Antonello Pietrangelo

2010

  • Autophagy in liver diseases
    December 2010 (Vol. 53 | No. 6 | Pages 1123-1134)

    Pierre-Emmanuel Rautou, Abdellah Mansouri, Didier Lebrec, François Durand, Dominique Valla, Richard Moreau

  • Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives
    December 2010 (Vol. 53 | No. 6 | Pages 1135-1145)

    Elsa Solà, Pere Ginès

  • Ageing, telomeres, senescence, and liver injury
    November 2010 (Vol. 53 | No. 5 | Pages 950-961)

    Matthew Hoare, Tapas Das, Graeme Alexander

  • Induced pluripotent stem cells: A new era for hepatology
    October 2010 (Vol. 53 | No. 4 | Pages 738-751)

    Samira Asgari, Behshad Pournasr, Ghasem Hosseini Salekdeh, Arefeh Ghodsizadeh, Michael Ott, Hossein Baharvand

  • Hepatitis C virus infection: A “liaison a trois” amongst the virus, the host, and chronic low-level inflammation for human survival
    October 2010 (Vol. 53 | No. 4 | Pages 752-761)

    Vincenzo Barnaba

  • Cirrhotic cardiomyopathy
    July 2010 (Vol. 53 | No. 1 | Pages 179-190)

    Søren Møller, Jens H. Henriksen

  • Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials
    July 2010 (Vol. 53 | No. 1 | Pages 191-198)

    Mieke M.H. Lamers, Martijn G.H. van Oijen, Martine Pronk, Joost P.H. Drenth

  • Primary biliary cirrhosis: A 2010 update
    May 2010 (Vol. 52 | No. 5 | Pages 745-758)

    Raoul Poupon

  • Risk of HCC: Genetic heterogeneity and complex genetics
    February 2010 (Vol. 52 | No. 2 | Pages 252-257)

    Tommaso A. Dragani

  • Liver disease associated with canalicular transport defects: Current and future therapies
    February 2010 (Vol. 52 | No. 2 | Pages 258-271)

    Janneke M. Stapelbroek, Karel J. van Erpecum, Leo W.J. Klomp, Roderick H.J. Houwen

  • Liver grafts from anti-hepatitis B core positive donors: A systematic review
    February 2010 (Vol. 52 | No. 2 | Pages 272-279)

    Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

  • The quest for liver progenitor cells: A practical point of view
    January 2010 (Vol. 52 | No. 1 | Pages 117-129)

    Laurent Dollé, Jan Best, Jie Mei, Feras Al Battah, Hendrik Reynaert, Leo A. van Grunsven, Albert Geerts

2009

  • Vinyl chloride and the liver
    December 2009 (Vol. 51 | No. 6 | Pages 1074-1081)

    Morris Sherman

  • The long and winding road leading to the identification of the hepatitis C virus
    November 2009 (Vol. 51 | No. 5 | Pages 939-948)

    Michael Houghton

  • Ethics in clinical research
    October 2009 (Vol. 51 | No. 4 | Pages 792-797)

    Silvio Garattini, Vittorio Bertele’

  • Transfusion-transmitted hepatitis B virus infection
    October 2009 (Vol. 51 | No. 4 | Pages 798-809)

    Daniel Candotti, Jean-Pierre Allain

  • Hepatitis C virus-induced hepatocarcinogenesis
    October 2009 (Vol. 51 | No. 4 | Pages 810-820)

    Birke Bartosch, Robert Thimme, Hubert E. Blum, Fabien Zoulim

  • New molecular insights into the mechanisms of cholestasis
    September 2009 (Vol. 51 | No. 3 | Pages 565-580)

    Martin Wagner, Gernot Zollner, Michael Trauner

  • Control of cccDNA function in hepatitis B virus infection
    September 2009 (Vol. 51 | No. 3 | Pages 581-592)

    Massimo Levrero, Teresa Pollicino, Jorg Petersen, Laura Belloni, Giovanni Raimondo, Maura Dandri

  • Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis – Overlapping or separate diseases?
    August 2009 (Vol. 51 | No. 2 | Pages 398-402)

    George J.M. Webster, Stephen P. Pereira, Roger W. Chapman

  • Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia
    August 2009 (Vol. 51 | No. 2 | Pages 403-410)

    Yun-Fan Liaw

  • Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation
    July 2009 (Vol. 51 | No. 1 | Pages 187-211)

    Sarah Snykers, Tom Henkens, Evelien De Rop, Mathieu Vinken, Joanna Fraczek, Joery De Kock, Evi De Prins, Albert Geerts, Vera Rogiers, Tamara Vanhaecke

  • Kupffer cells in non-alcoholic fatty liver disease: The emerging view
    July 2009 (Vol. 51 | No. 1 | Pages 212-223)

    György Baffy

  • Signalling pathways in alcohol-induced liver inflammation
    June 2009 (Vol. 50 | No. 6 | Pages 1258-1266)

    Pranoti Mandrekar, Gyongyi Szabo

  • Hepatitis D: Thirty years after
    May 2009 (Vol. 50 | No. 5 | Pages 1043-1050)

    Mario Rizzetto

  • Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
    April 2009 (Vol. 50 | No. 4 | Pages 805-816)

    Ding-Shinn Chen

  • Clinical trial design and evidence-based outcomes in the study of liver diseases
    April 2009 (Vol. 50 | No. 4 | Pages 817-826)

    Jennifer M. Croswell, Barnett S. Kramer

  • Angiogenesis in liver disease
    March 2009 (Vol. 50 | No. 3 | Pages 604-620)

    Mercedes Fernández, David Semela, Jordi Bruix, Isabelle Colle, Massimo Pinzani, Jaume Bosch

  • Ribavirin: Current role in the optimal clinical management of chronic hepatitis C
    February 2009 (Vol. 50 | No. 2 | Pages 402-411)

    K. Rajender Reddy, David R. Nelson, Stefan Zeuzem

  • Treatment failure in hepatitis C: Mechanisms of non-response
    February 2009 (Vol. 50 | No. 2 | Pages 412-420)

    Andrew W. Tai, Raymond T. Chung

  • Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges
    January 2009 (Vol. 50 | No. 1 | Pages 184-194)

    Alex Thompson, Keyur Patel, Hans Tillman, John G. McHutchison

  • Primary Budd-Chiari syndrome
    January 2009 (Vol. 50 | No. 1 | Pages 195-203)

    Dominique-Charles Valla

  • Epidemiology of non-alcoholic fatty liver disease in China
    January 2009 (Vol. 50 | No. 1 | Pages 204-210)

    Jian-Gao Fan, Geoffrey C. Farrell

2008

  • Plasmacytoid dendritic cells move down on the list of suspects: In search of the immune pathogenesis of chronic hepatitis C
    December 2008 (Vol. 49 | No. 6 | Pages 1069-1078)

    Matthew L. Albert, Jérémie Decalf, Stanislas Pol

  • The importance of immune dysfunction in determining outcome in acute liver failure
    November 2008 (Vol. 49 | No. 5 | Pages 845-861)

    Charalambos Gustav Antoniades, Philip A. Berry, Julia A. Wendon, Diego Vergani

  • Hepatitis C virus and kidney disease
    October 2008 (Vol. 49 | No. 4 | Pages 613-624)

    Paul Martin, Fabrizio Fabrizi

  • Acute hepatitis C: Current status and remaining challenges
    October 2008 (Vol. 49 | No. 4 | Pages 625-633)

    Teresa Santantonio, Johannes Wiegand, J. Tilman Gerlach

  • Treatment predictors of a sustained virologic response in hepatitis B and C
    October 2008 (Vol. 49 | No. 4 | Pages 634-651)

    Annika Kau, Johannes Vermehren, Christoph Sarrazin

  • The unfinished business of primary biliary cirrhosis
    September 2008 (Vol. 49 | No. 3 | Pages 451-460)

    Carlo Selmi, Massimo Zuin, M. Eric Gershwin

  • Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
    August 2008 (Vol. 49 | No. 2 | Pages 274-287)

    Marina Berenguer

  • Mouse models for the study of HCV infection and virus–host interactions
    July 2008 (Vol. 49 | No. 1 | Pages 134-142)

    Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert

  • Thrombocytopenia associated with chronic liver disease
    June 2008 (Vol. 48 | No. 6 | Pages 1000-1007)

    Nezam Afdhal, John McHutchison, Robert Brown, Ira Jacobson, Michael Manns, Fred Poordad, Babette Weksler, Rafael Esteban

  • Allogeneic hematopoietic cell transplant in HCV-infected patients
    June 2008 (Vol. 48 | No. 6 | Pages 1008-1017)

    Régis Peffault de Latour, Patricia Ribaud, Marie Robin, Dominique Valla, Patrick Marcellin, Gérard Socié, Tarik Asselah

  • Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma
    May 2008 (Vol. 48 | No. 5 | Pages 848-857)

    Riccardo Lencioni, Fabio Piscaglia, Luigi Bolondi

  • Experimental models of hepatocellular carcinoma
    May 2008 (Vol. 48 | No. 5 | Pages 858-879)

    Philippa Newell, Augusto Villanueva, Scott L. Friedman, Kazuhiko Koike, Josep M. Llovet

  • miR-122, a paradigm for the role of microRNAs in the liver
    April 2008 (Vol. 48 | No. 4 | Pages 648-656)

    Muriel Girard, Emmanuel Jacquemin, Arnold Munnich, Stanislas Lyonnet, Alexandra Henrion-Caude

  • Environmental factors as disease accelerators during chronic hepatitis C
    April 2008 (Vol. 48 | No. 4 | Pages 657-665)

    Ariane Mallat, Christophe Hezode, Sophie Lotersztajn

  • The function of serotonin within the liver
    April 2008 (Vol. 48 | No. 4 | Pages 666-675)

    Richard G. Ruddell, Derek A. Mann, Grant A. Ramm

  • Hepatitis E: An emerging awareness of an old disease
    March 2008 (Vol. 48 | No. 3 | Pages 494-503)

    R.H. Purcell, S.U. Emerson

  • Leukocyte adhesion in the liver: Distinct adhesion paradigm from other organs
    March 2008 (Vol. 48 | No. 3 | Pages 504-512)

    Woo-Yong Lee, Paul Kubes

  • Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
    February 2008 (Vol. 48 | No. 2 | Pages 335-352)

    Giovanna Fattovich, Flavia Bortolotti, Francesco Donato

  • Viral hepatitis and HIV coinfection
    February 2008 (Vol. 48 | No. 2 | Pages 353-367)

    Mark S. Sulkowski

  • The changing epidemiology of hepatitis C virus infection in Europe
    January 2008 (Vol. 48 | No. 1 | Pages 148-162)

    Juan I. Esteban, Silvia Sauleda, Josep Quer

  • Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma
    January 2008 (Vol. 48 | No. 1 | Pages 163-170)

    Sandra Rebouissou, Paulette Bioulac-Sage, Jessica Zucman-Rossi

2007

  • Omega 3 – Omega 6: What is right for the liver?
    November 2007 (Vol. 47 | No. 5 | Pages 718-725)

    Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien

  • Grading and staging systems for inflammation and fibrosis in chronic liver diseases
    October 2007 (Vol. 47 | No. 4 | Pages 598-607)

    Zachary D. Goodman

  • Economics of chronic hepatitis B and hepatitis C
    October 2007 (Vol. 47 | No. 4 | Pages 608-617)

    Arathi Rajendra, John B. Wong

  • Adrenal insufficiency in liver disease – What is the evidence?
    September 2007 (Vol. 47 | No. 3 | Pages 418-423)

    James O’Beirne, Michael Holmes, Banwari Agarwal, Pierre Bouloux, Steve Shaw, David Patch, Andrew Burroughs

  • Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem?
    June 2007 (Vol. 46 | No. 6 | Pages 1133-1142)

    Eve A. Roberts

  • Transjugular liver biopsy – Indications, adequacy, quality of specimens, and complications – A systematic review
    August 2007 (Vol. 47 | No. 2 | Pages 284-294)

    George Kalambokis, Pinelopi Manousou, Shusang Vibhakorn, Laura Marelli, Evangelos Cholongitas, Marco Senzolo, David Patch, Andrew K. Burroughs

  • Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem?
    June 2007 (Vol. 46 | No. 6 | Pages 1133-1142)

    Eve A. Roberts

  • Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences
    July 2007 (Vol. 47 | No. 1 | Pages 142-156)

    Isabelle A. Leclercq, Alain Da Silva Morais, Ben Schroyen, Noémi Van Hul, Albert Geerts

  • Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem?
    June 2007 (Vol. 46 | No. 6 | Pages 1133-1142)

    Eve A. Roberts

  • Vascular endothelial dysfunction in cirrhosis
    May 2007 (Vol. 46 | No. 5 | Pages 927-934)

    Yasuko Iwakiri, Roberto J. Groszmann

  • Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome
    May 2007 (Vol. 46 | No. 5 | Pages 935-946)

    Vicente Arroyo, Carlos Terra, Pere Ginès

  • Methodology of superiority vs. equivalence trials and non-inferiority trials
    May 2007 (Vol. 46 | No. 5 | Pages 947-954)

    Erik Christensen

  • HBV pathogenesis in animal models: Recent advances on the role of platelets
    April 2007 (Vol. 46 | No. 4 | Pages 719-726)

    Matteo Iannacone, Giovanni Sitia, Zaverio M. Ruggeri, Luca G. Guidotti

  • Abnormalities of hemostasis in chronic liver disease: Reappraisal of their clinical significance and need for clinical and laboratory research
    April 2007 (Vol. 46 | No. 4 | Pages 727-733)

    Armando Tripodi, Pier Mannuccio Mannucci

  • Hepatology may have problems with putative surrogate outcome measures
    April 2007 (Vol. 46 | No. 4 | Pages 734-742)

    Christian Gluud, Jesper Brok, Yan Gong, Ronald L. Koretz

  • Liver involvement in hereditary hemorrhagic telangiectasia (HHT)
    March 2007 (Vol. 46 | No. 3 | Pages 499-507)

    Guadalupe Garcia-Tsao

  • Liver transplantation in children
    February 2007 (Vol. 46 | No. 2 | Pages 340-348)

    Paolo Muiesan, Diego Vergani, Giorgina Mieli-Vergani

  • Occult hepatitis B virus infection
    January 2007 (Vol. 46 | No. 1 | Pages 160-170)

    Giovanni Raimondo, Teresa Pollicino, Irene Cacciola, Giovanni Squadrito

2006

  • Cholangiocarcinoma: Modern advances in understanding a deadly old disease
    December 2006 (Vol. 45 | No. 6 | Pages 856-867)

    Harmeet Malhi, Gregory J. Gores

  • Immunotherapy of hepatocellular carcinoma
    December 2006 (Vol. 45 | No. 6 | Pages 868-878)

    Tim F. Greten, Michael P. Manns, Firouzeh Korangy

  • Large liver cell dysplasia: A controversial entity
    November 2006 (Vol. 45 | No. 5 | Pages 734-743)

    Young Nyun Park, Massimo Roncalli

  • The intestinal flora and bacterial infection in cirrhosis
    November 2006 (Vol. 45 | No. 5 | Pages 744-757)

    Stephen M. Riordan, Roger Williams

  • Transmission of hepatitis C virus by blood transfusions and other medical procedures: A global review
    October 2006 (Vol. 45 | No. 4 | Pages 607-616)

    Daniele Prati

  • The hepatopulmonary syndrome
    October 2006 (Vol. 45 | No. 4 | Pages 617-625)

    David T. Palma, Michael B. Fallon

  • Treatment of bone disorders in liver disease
    September 2006 (Vol. 45 | No. 3 | Pages 445-453)

    Albert Parés, Núria Guañabens

  • ER stress: Can the liver cope?
    August 2006 (Vol. 45 | No. 2 | Pages 321-333)

    Cheng Ji, Neil Kaplowitz

  • Present status and perspectives of cell-based therapies for liver diseases
    July 2006 (Vol. 45 | No. 1 | Pages 144-159)

    Andreas Nussler, Sarah Konig, Michael Ott, Etienne Sokal, Bruno Christ, Wolfgang Thasler, Marc Brulport, Geredn Gabelein, Wiebke Schormann, Maren Schulze, Ewa Ellis, Matthias Kraemer, Frank Nocken, Wolfgang Fleig, Michael Manns, Steven C. Strom, Jan G. Hengstler

  • ‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis
    June 2006 (Vol. 44 | No. 6 | Pages 1196-1207)

    Amedeo Lonardo, Cesare Carani, Nicola Carulli, Paola Loria

  • The role of apoptosis versus oncotic necrosis in liver injury: Facts or faith?
    May 2006 (Vol. 44 | No. 5 | Pages 984-993)

    Henning Schulze-Bergkamen, Marcus Schuchmann, Binje Fleischer, Peter R. Galle

  • Cardiac electrophysiological abnormalities in patients with cirrhosis
    May 2006 (Vol. 44 | No. 5 | Pages 994-1002)

    Andrea Zambruni, Franco Trevisani, Paolo Caraceni, Mauro Bernardi

  • Molecular prognostication of liver cancer: End of the beginning
    April 2006 (Vol. 44 | No. 4 | Pages 798-805)

    Snorri S. Thorgeirsson, Ju-Seog Lee, Joe W. Grisham

  • Ischemic cholangiopathy
    April 2006 (Vol. 44 | No. 4 | Pages 806-817)

    Pierre Deltenre, Dominique-Charles Valla

  • HBV drug resistance: Mechanisms, detection and interpretation
    March 2006 (Vol. 44 | No. 3 | Pages 593-606)

    Tim Shaw, Angeline Bartholomeusz, Stephen Locarnini

  • The culture of designing hepato-biliary randomised trials
    March 2006 (Vol. 44 | No. 3 | Pages 607-615)

    Christian Gluud

  • The face of future hepatitis C antiviral drug development: Recent biological and virologic advances and their translation to drug development and clinical practice
    February 2006 (Vol. 44 | No. 2 | Pages 411-421)

    John G. McHutchison, Ralf Bartenschlager, Keyur Patel, Jean-Michel Pawlotsky

  • Cellular and virological mechanisms of HBV drug resistance
    February 2006 (Vol. 44 | No. 2 | Pages 422-431)

    Stephen Locarnini, William S. Mason

  • Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis
    January 2006 (Vol. 44 | No. 1 | Pages 209-216)

    Daniel A. Langer, Vijay H. Shah

  • Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
    January 2006 (Vol. 44 | No. 1 | Pages 217-231)

    Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi Pagliaro

2005

  • The pruritus of cholestasis
    December 2005 (Vol. 43 | No. 6 | Pages 1078-1088)

    Nora V. Bergasa

  • Herbal hepatotoxicity
    November 2005 (Vol. 43 | No. 5 | Pages 901-910)

    Felix Stickel, Eleonora Patsenker, Detlef Schuppan

  • Reading and critically appraising systematic reviews and meta-analyses: A short primer with a focus on hepatology
    October 2005 (Vol. 43 | No. 4 | Pages 729-736)

    Ethan M. Balk, Joseph Lau, Peter A.L. Bonis

  • Corticosteroids for alcoholic hepatitis—what's next?
    September 2005 (Vol. 43 | No. 3 | Pages 526-533)

    Philippe Mathurin

  • Enterohepatic transport of bile salts and genetics of cholestasis
    August 2005 (Vol. 43 | No. 2 | Pages 342-357)

    Christiane Pauli-Magnus, Bruno Stieger, Yvonne Meier, Gerd A. Kullak-Ublick, Peter J. Meier

  • Proteomics in the study of liver pathology
    July 2005 (Vol. 43 | No. 1 | Pages 177-183)

    Romain Parent, Laura Beretta

  • NASH: a mitochondrial disease
    June 2005 (Vol. 42 | No. 6 | Pages 928-940)

    Dominique Pessayre, Bernard Fromenty

  • The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma
    May 2005 (Vol. 42 | No. 5 | Pages 760-777)

    Ruben Bonilla Guerrero, Lewis R. Roberts

  • Regulated vesicle trafficking of membrane transporters in hepatic epithelia
    April 2005 (Vol. 42 | No. 4 | Pages 592-603)

    Raúl A. Marinelli, Pamela S. Tietz, Nicholas F. LaRusso

  • The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection?
    March 2005 (Vol. 42 | No. 3 | Pages 408-417)

    David G. Bowen, Christopher M. Walker

  • Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels
    February 2005 (Vol. 42 | No. 2 | Pages 266-274)

    Alfredo Alberti

  • The potential of RNA interference as a tool in the management of viral hepatitis
    January 2005 (Vol. 42 | No. 1 | Pages 139-144)

    John A. Taylor, Nikolai V. Naoumov

2004

  • Angiogenesis and hepatocellular carcinoma
    November 2004 (Vol. 41 | No. 5 | Pages 864-880)

    David Semela, Jean-François Dufour

  • Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma
    September 2004 (Vol. 41 | No. 3 | Pages 491-497)

    André Lechel, Michael P. Manns, K.Lenhard Rudolph

  • Prognostic models including the Child–Pugh, MELD and Mayo risk scores—where are we and where should we go?
    August 2004 (Vol. 41 | No. 2 | Pages 344-350)

    Erik Christensen

  • Hepatitis viruses and human immunodeficiency virus co-infection: pathogenisis and treatment
    July 2004 (Vol. 41 | No. 1 | Pages 156-166)

    Anaı̈s Vallet-Pichard, Stanislas Pol

  • Genetic alterations in hepatocellular adenomas: recent findings and new challenges
    June 2004 (Vol. 40 | No. 6 | Pages 1036-1039)

    Jessica Zucman-Rossi

  • Cirrhosis reversal: a duel between dogma and myth
    May 2004 (Vol. 40 | No. 5 | Pages 860-867)

    Valeer J Desmet, Tania Roskams

  • Intestinal absorption of iron in HFE-1 hemochromatosis: local or systemic process?
    April 2004 (Vol. 40 | No. 4 | Pages 702-709)

    Pierre Brissot, Marie-Bérengère Troadec, Olivier Loréal

  • Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
    March 2004 (Vol. 40 | No. 3 | Pages 539-551)

    John Y.L Chiang

  • Extrahepatic disease manifestations of HCV infection: some current issues
    February 2004 (Vol. 40 | No. 2 | Pages 341-352)

    Vincent Agnello, Francesco G. De Rosa

  • Magnetic resonance imaging of liver tumors
    January 2004 (Vol. 40 | No. 1 | Pages 162-171)

    Riccardo Lencioni, Dania Cioni, Laura Crocetti, Clotilde Della Pina, Carlo Bartolozzi

2003

  • Screening for hepatocellular carcinoma in cirrhosis
    December 2003 (Vol. 39 | No. 6 | Pages 1076-1084)

    Luigi Bolondi

  • Pathogenesis of primary biliary cirrhosis
    October 2003 (Vol. 39 | No. 4 | Pages 639-648)

    David E.J Jones

  • Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids
    September 2003 (Vol. 39 | No. 3 | Pages 437-446)

    Mario Chojkier

  • Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies
    August 2003 (Vol. 39 | No. 2 | Pages 278-285)

    Roger F Butterworth

  • Translation of immunological knowledge into better treatments of chronic hepatitis B
    July 2003 (Vol. 39 | No. 1 | Pages 115-124)

    Antonio Bertoletti, Nikolai V Naoumov

  • Osteoporosis in liver diseases and after liver transplantation
    June 2003 (Vol. 38 | No. 6 | Pages 856-865)

    J.Eileen Hay

  • Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics
    May 2003 (Vol. 38 | No. 5 | Pages 681-687)

    Steven F. Solga, A.M. Diehl

  • Inherited disorders of bilirubin metabolism
    January 2003 (Vol. 38 | No. 1 | Pages 107-117)

    Piter Jabik Bosma

2002

  • The challenge of developing a vaccine against hepatitis C virus
    November 2002 (Vol. 37 | No. 5 | Pages 684-695)

    Xavier Forns, Jens Bukh, Robert H Purcell

  • Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research
    October 2002 (Vol. 37 | No. 4 | Pages 527-535)

    David Cassiman, Tania Roskams

  • Death receptor-mediated apoptosis and the liver
    September 2002 (Vol. 37 | No. 3 | Pages 400-410)

    Jung-Hwan Yoon, Gregory J Gores

  • Haemostatic abnormalities in patients with liver disease
    August 2002 (Vol. 37 | No. 2 | Pages 280-287)

    Ton Lisman, Frank W.G. Leebeek, Philip G. de Groot

  • Nuclear receptor regulation of hepatic function
    June 2002 (Vol. 36 | No. 6 | Pages 832-850)

    Saul J. Karpen

  • Liver stem cells and model systems for liver repopulation
    April 2002 (Vol. 36 | No. 4 | Pages 552-564)

    David A Shafritz, Mariana D Dabeva

  • Antiretroviral drug toxicity – a challenge for the hepatologist?
    February 2002 (Vol. 36 | No. 2 | Pages 283-294)

    Ulrich Spengler, Mathias Lichterfeld, Jürgen Kurt Rockstroh

2001

  • Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E
    December 2001 (Vol. 35 | No. 6 | Pages 816-822)

    Arjen R Mensenkamp, Louis M Havekes, Johannes A Romijn, Folkert Kuipers

  • Hepatitis C and liver transplantation
    November 2001 (Vol. 35 | No. 5 | Pages 666-678)

    Marina Berenguer, F.Xavier López-Labrador, Teresa L. Wright

  • The spectrum of liver disease in the general population: lesson from the Dionysos study
    October 2001 (Vol. 35 | No. 4 | Pages 531-537)

    Stefano Bellentani, Claudio Tiribelli

  • Oxidative stress-related molecules and liver fibrosis
    August 2001 (Vol. 35 | No. 2 | Pages 297-306)

    Maurizio Parola, Gaia Robino

  • Ursodeoxycholic acid ‘mechanisms of action and clinical use in hepatobiliary disorders’
    July 2001 (Vol. 35 | No. 1 | Pages 134-146)

    Konstantinos N Lazaridis, Gregory J Gores, Keith D Lindor

  • Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes
    June 2001 (Vol. 34 | No. 6 | Pages 946-954)

    Christine L Hammond, Thomas K Lee, Nazzareno Ballatori

  • Neuropsychological characterization of hepatic encephalopathy
    May 2001 (Vol. 34 | No. 5 | Pages 768-773)

    Karin Weissenborn, Jochen C Ennen, Hans Schomerus, Norbert Rückert, Hartmut Hecker

  • Live donor liver transplantation
    April 2001 (Vol. 34 | No. 4 | Pages 613-624)

    Elizabeth A. Pomfret, James J. Pomposelli, Roger L. Jenkins

  • Vascularity of liver tumours and recent advances in Doppler ultrasound
    March 2001 (Vol. 34 | No. 3 | Pages 474-482)

    Stefano Gaiani, Laura Volpe, Fabio Piscaglia, Luigi Bolondi

  • The Wilson's disease gene and phenotypic diversity
    January 2001 (Vol. 34 | No. 1 | Pages 165-171)

    Stephen M Riordan, Roger Williams

2000

  • Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management
    December 2000 (Vol. 33 | No. 6 | Pages 1012-1021)

    Frank Lammert, Hanns-Ulrich Marschall, Anna Glantz, Siegfried Matern

  • Radiofrequency ablation in the treatment of hepatocellular carcinoma - a clinical viewpoint
    October 2000 (Vol. 33 | No. 4 | Pages 667-672)

    Alessandro Grasso, Anthony F Watkinson, Jonathan M Tibballs, Andrew K Burroughs

  • Regulation and deregulation of cholangiocyte proliferation
    August 2000 (Vol. 33 | No. 2 | Pages 333-340)

    Domenico Alvaro, Alessandro Gigliozzi, Adolfo F Attili

  • Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?
    June 2000 (Vol. 32 | No. 6 | Pages 1035-1038)

    Dieter Häussinger, Gerald Kircheis, Richard Fischer, Freimut Schliess, Stephan vom Dahl

  • Portal vein thrombosis in adults: pathophysiology, pathogenesis and management
    May 2000 (Vol. 32 | No. 5 | Pages 865-871)

    Dominique-Charles Valla, Bertrand Condat

  • Mallory bodies revisited
    April 2000 (Vol. 32 | No. 4 | Pages 689-702)

    Helmut Denk, Cornelia Stumptner, Kurt Zatloukal

  • Preservation injury of the liver: mechanisms and novel therapeutic strategies
    March 2000 (Vol. 32 | No. 3 | Pages 508-515)

    Manfred Bilzer, Alexander L Gerbes

  • The potential of gene therapy in the treatment of hepatocellular carcinoma
    February 2000 (Vol. 32 | No. 2 | Pages 344-351)

    Cheng Qian, Marek Drozdzik, Wolfgang H Caselmann, Jesús Prieto

  • Mitochondrial membrane perturbations in cholestasis
    January 2000 (Vol. 32 | No. 1 | Pages 135-141)

    Cecília M.P Rodrigues, Clifford J Steer

1999

  • Regulation of organic anion and drug transporters of the sinusoidal membrane
    September 1999 (Vol. 31 | No. 3 | Pages 563-573)

    Gerd A Kullak-Ublick

  • Extrahepatic manifestations of HCV infection: facts and controversies
    August 1999 (Vol. 31 | No. 2 | Pages 369-376)

    Anna Linda Zignego, Christian Bréchot

  • Genetic basis of progressive familial intrahepatic cholestasis
    August 1999 (Vol. 31 | No. 2 | Pages 377-381)

    Emmanuel Jacquemin, Michelle Hadchouel

  • Molecular regulation of hepatocellular transport systems in cholestasis
    July 1999 (Vol. 31 | No. 1 | Pages 165-178)

    Michael Trauner, Peter J. Meier, James L. Boyer

  • Regulation of cholangiocyte bile secretion
    July 1999 (Vol. 31 | No. 1 | Pages 179-191)

    Leonardo Baiocchi, Gene LeSage, Shannon Glaser, Gianfranco Alpini

  • The outcome of hepatitis C virus infection after liver transplantation - is it influenced by the type of immunosuppression?
    April 1999 (Vol. 30 | No. 4 | Pages 731-738)

    George V Papatheodoridis, David Patch, Geoffrey M Dusheiko, Andrew K Burroughs

  • Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients
    March 1999 (Vol. 30 | No. 3 | Pages 536-550)

    Stephen Locarnini, Chris Birch

  • DNA vaccine strategies for hepatitis C
    February 1999 (Vol. 30 | No. 2 | Pages 339-346)

    Geneviève Inchauspé